These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15749685)

  • 21. Additive effects of the chemokine receptor 2, vitamin D receptor, interleukin-6 polymorphisms and cardiovascular risk factors on the prevalence of myocardial infarction in patients below 65 years.
    Ortlepp JR; Krantz C; Kimmel M; von Korff A; Vesper K; Schmitz F; Mevissen V; Janssens U; Franke A; Hanrath P; Zerres K; Hoffmann R
    Int J Cardiol; 2005 Oct; 105(1):90-5. PubMed ID: 16207551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years.
    Rallidis LS; Politou M; Komporozos C; Panagiotakos DB; Belessi CI; Travlou A; Lekakis J; Kremastinos DT
    Thromb Haemost; 2008 Jun; 99(6):1085-9. PubMed ID: 18521512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
    Ozmen F; Ozmen MM; Ozalp N; Akar N
    Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of inherited prothrombotic risk factors on individuals chronically infected with hepatitis C virus from a single source.
    Goulding C; O'Brien C; Egan H; Hegarty JE; McDonald G; O'Farrelly C; White B; Kelleher D; Norris S
    J Viral Hepat; 2007 Apr; 14(4):255-9. PubMed ID: 17381717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia.
    Bedencic M; Bozic M; Peternel P; Stegnar M
    Pathophysiol Haemost Thromb; 2008; 36(2):58-63. PubMed ID: 19127083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Common genetic variation in the prothrombin gene, hormone therapy, and incident nonfatal myocardial infarction in postmenopausal women.
    Hindorff LA; Psaty BM; Carlson CS; Heckbert SR; Lumley T; Smith NL; Lemaitre RN; Rieder MJ; Nickerson DA; Reiner AP
    Am J Epidemiol; 2006 Apr; 163(7):600-7. PubMed ID: 16467413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between PPARalpha gene polymorphisms and myocardial infarction.
    Reinhard W; Stark K; Sedlacek K; Fischer M; Baessler A; Neureuther K; Weber S; Kaess B; Wiedmann S; Mitsching S; Lieb W; Erdmann J; Meisinger C; Doering A; Tolle R; Jeron A; Riegger G; Hengstenberg C
    Clin Sci (Lond); 2008 Nov; 115(10):301-8. PubMed ID: 18336366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between platelet glycoprotein Ib-alpha and myocardial infarction: results of a pilot study performed in male and female patients from Sicily.
    Candore G; Piazza G; Crivello A; Grimaldi MP; Orlando V; Caruso M; Caimi G; Hoffmann E; Incalcaterra E; Lio D; Caruso C
    Ann N Y Acad Sci; 2006 Nov; 1089():502-8. PubMed ID: 17261793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase 1 promoter polymorphisms and risk of myocardial infarction: a case-control study in a Spanish population.
    Román-García P; Coto E; Reguero JR; Cannata-Andía JB; Lozano I; Avanzas P; Morís C; Rodríguez I
    Coron Artery Dis; 2009 Sep; 20(6):383-6. PubMed ID: 19620856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prothrombin A19911G polymorphism and the risk of venous thromboembolism.
    Martinelli I; Battaglioli T; Tosetto A; Legnani C; Sottile L; Ghiotto R; Mannucci PM
    J Thromb Haemost; 2006 Dec; 4(12):2582-6. PubMed ID: 16981886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction.
    Hernández-Romero D; Marín F; Lee KW; Roldán V; Caturla J; Corral J; Valdés M; Lip GY; Vicente V; González-Conejero R
    Thromb Haemost; 2010 Sep; 104(3):650-2. PubMed ID: 20589311
    [No Abstract]   [Full Text] [Related]  

  • 33. Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.
    Koch W; Hoppmann P; Mueller JC; Schömig A; Kastrati A
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1114-9. PubMed ID: 16543493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects.
    Helfenstein T; Fonseca FA; Relvas WG; Santos AO; Dabela ML; Matheus SC; D'Almeida V; Tufik S; Souza FG; Rodrigues PR; Taglieri R; Sousa EF; Izar MC
    Clin Chim Acta; 2005 May; 355(1-2):165-72. PubMed ID: 15820491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level.
    Le Cam-Duchez V; Soria C; Dit Sollier CB; Borg JY; Coudert M; Montalescot G; Esposito G; Drouet L; Collet JP
    Thromb Haemost; 2009 Jul; 102(1):131-6. PubMed ID: 19572077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR; García-Sanz R; Alberca I; López ML; Balanzategui A; Gutierrez O; Lozano F; San Miguel J
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of factor V G1691A (Leiden) and prothrombin G20210A polymorphisms among apparently healthy Jordanians.
    Nusier MK; Radaideh AM; Ababneh NA; Qaqish BM; Alzoubi R; Khader Y; Mersa JY; Irshaid NM; El-Khateeb M
    Neuro Endocrinol Lett; 2007 Oct; 28(5):699-703. PubMed ID: 17984931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [P1 A2: a new genetic risk factor for myocardial infarction].
    Bernát SI; Metz E; Gonda F; Torday A
    Orv Hetil; 1998 Sep; 139(39):2319-21. PubMed ID: 9789986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A; Egin Y; Cam R; Akar N
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
    Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.